Clean Sweep Live Auction on Thur. March 28th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment




Cardiology Homepage

Apple study suggests wearable technology may be useful in detecting atrial fibrillation May assist in stroke and hospitalization prevention

FDA gives green light for smallest, slimmest 3T CRM devices Extended battery lives, greater diagnostic and therapeutic capabilities

Echocardiogram should play role in patient selection for transcatheter mitral valve repair, says study New study highlighted at ACC

Level Ex releases interventional cardiac video game, Cardio Ex Over 35 levels that test cognitive, spatial reasoning and decision-making skills

Siemens to unveil its SOMATOM go.Top Cardiovascular Edition CT at ACC 19 Ideal for the cardiovascular outpatient setting

FDA approves Sonavex's EchoSure system Monitors blood flow following surgical procedures

Siemens unveils Artis icono biplane angio system at ECR Enables diagnostics and treatment to take place in same lab, improved 2D and 3D capabilities

Personalized cardiac test could eliminate unnecessary catheterizations Examines flow of blood with AI and CT

Noninvasive approach for imaging carotid artery shows promise Enables risk assessment for cardiovascular disease

Medtronic to acquire EPIX Therapeutics Will use EPIX's cardiac ablation technology with Medtronic's cryoballoon technology

Intra-Operative Positioning System

Centerline Biomedical submits IOPS system for FDA clearance

by John R. Fischer , Staff Reporter
Centerline Biomedical has turned over its Intra-Operative Positioning System (IOPS) to the FDA in the hopes of gaining the agency’s stamp of approval to commence shipments throughout the U.S.

A non-radiation-based surgical navigation system, IOPS was developed at Cleveland Clinic’s Heart and Vascular Institute as alternative for overcoming the risks and visualization challenges of X-ray fluoroscopy.

Story Continues Below Advertisement

Has exclusive distribution agreement with DDD to sell new Camera systems

UMRi provides the very best new & refurbished gamma cameras, quality parts &repair services. We also rebuild & replace camera detectors, move camera systems across town or across the country. Call us at 888-239-3510

“The visual challenges clinicians face when using fluoroscopy for minimally-invasive interventions in the cardiovascular system revolve around the poor visualization of soft tissue and the image as a two-dimensional projection,” Vikash Goel, chief technology officer for Centerline Biomedical, told HCB News. “Soft tissue, such as arteries and veins, does not attenuate X-rays enough to show up well on a fluoroscopic image. Blood vessels are also remarkably complex in geometry and looking at a flat projection of complex three-dimensional shapes can be very limiting when clinicians are trying to traverse the anatomy.”

The visualization of soft tissue can be improved with the use of radiopaque contrast medium, which temporarily makes the bloodstream visible on fluoroscopic images. The contrast dye, however, is toxic to the kidneys and must be applied in limited use. In addition, exposure to X-ray fluoroscopy raises the chances of patients developing cancer at some point in their life.

IOPS is equipped to extract never-before encoded information using AI and machine learning, and convert it with Centerline’s navigation technology, which is based on a proprietary vessel mapping system, into a concise and mathematically meaningful anatomical model.

The company plans to further build the product up to make use of the models with the creation of a database of procedures, comprising data about anatomical information and the use of endovascular devices. It also hopes for the data in aggregate to become the basis of a cloud-based platform that supports clinicians.

“By applying existing machine learning algorithms to these data, we hope to be able to match incoming cases to historical cases with anatomical similarities and facilitate the use of past experience to strengthen future interventions,” said Goel.

Upon gaining FDA clearance, the IOPS system will be available for use in endovascular aortic interventions, with the company planning to extend its indication through further developments.

Series B funding for product is currently taking place to prepare for its eventual market entry.

Back to HCB News
  Pages: 1

Cardiology Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.